Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.

Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.

Abstract: A dental device with a speech recognition module is provided, which is connected to a control device that controls at least part of the functions of the dental device. Based on the recognition result, the speech recognition module triggers a selected function of the dental device via the control device and has at least one microphone. An output module outputs information about the triggered function. The speech recognition module continuously listens via the microphone and has a code word module that activates or leaves active speech recognition for the temporally successive words when a code word is recognized and attempts to recognize them as predetermined control words each assigned to a function.